Composition Comprising Biosurfactant and Salicylic Acid
Summary
USPTO published L'OREAL's patent application for a skincare composition combining glycolipid biosurfactants with salicylic acid derivatives, cationic polymers, and clay for treating acne-prone skin. The application, filed September 30, 2024, covers formulations with water and glycerin solvents for topical use.
What changed
L'OREAL filed patent application US20260090964A1 covering compositions comprising (a) glycolipid biosurfactants, (b) salicylic acid or derivatives, (c) cationic polymers from β-linked D-glucosamine and N-acetyl-D-glucosamine, (d) clay, and (e) cosmetically acceptable solvents. The formulation targets acne-prone skin with hydrating and cleansing effects. The inventors are Christopher Pang, Changlong Chen, Siliu Tan, and Mariko Hasebe.
This publication is informational—patent applications do not create immediate compliance obligations or require action from regulated entities. Cosmetics and personal care manufacturers should note the biosurfactant and salicylic acid combination for potential competitive monitoring of L'OREAL's product pipeline. No response or filing is required.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITION COMPRISING BIOSURFACTANT AND SALICYLIC ACID
Application US20260090964A1 Kind: A1 Apr 02, 2026
Assignee
L'OREAL
Inventors
Christopher PANG, Changlong CHEN, Siliu TAN, Mariko HASEBE
Abstract
The present invention relates to compositions comprising (a) at least one glycolipid; (b) at least one salicylic acid or its derivatives represented by formula (I); (c) at least one cationic polymer may be a polysaccharide derived from β-linked D-glucosamine and N-acetyl-D-glucosamine; (d) at least one clay; and (e) cosmetically acceptable solvents comprising water, glycerin. The compositions according to the present invention can provide an effect of treating, hydrating, and/or cleansing acne-prone skin.
CPC Classifications
A61K 8/365 A61K 8/0212 A61K 8/602 A61Q 19/10
Filing Date
2024-09-30
Application No.
18901492
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.